TransMedics Group is trading 4.1% up at $79.60, rebounding from the 5.28% decline on August 5 as investors continue processing the August 4 earnings report.

  • No new company-specific announcement or analyst action clearly explains the August 6 move.
  • The report showed strong revenue growth but weaker EPS, higher expenses, margin pressure, and reduced operating-margin guidance.